Clinical Trial Update: Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating cannabidiol oral solution in pediatric participants with treatment-resistant seizure disorders has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Cannabidiol Oral Solution (cannabidiol)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Seizures | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-23